Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delayed onset of liver injury after intentional chloroform overdose: a case report and literature review.

Acute medicine·2019
Same author

Global research production in glyphosate intoxication from 1978 to 2015: A bibliometric analysis.

Human & experimental toxicology·2016
Same author

Global research productivity of N-acetylcysteine use in paracetamol overdose: A bibliometric analysis (1976-2012).

Human & experimental toxicology·2015
Same author

Scientific research related to calcium channel blockers poisoning: Bibliometric analysis in Scopus, 1968-2012.

Human & experimental toxicology·2015
Same author

Impact of amending the acetylcysteine marketing authorisation on treatment of paracetamol overdose.

ISRN toxicology·2013
Same author

Unplanned alcohol withdrawal: a survey of consecutive admissions to an acute medical unit in 2010 and 2011.

QJM : monthly journal of the Association of Physicians·2012

Related Experiment Video

Updated: May 18, 2026

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
12:21

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram

Published on: November 27, 2016

Citalopram and cardiac toxicity.

M J Cooke1, W S Waring

  • 1Pharmacy Department, York Teaching Hospital NHS Foundation Trust, Wigginton Road, York, YO31 8HE, UK.

European Journal of Clinical Pharmacology
|September 22, 2012
PubMed
Summary

High doses of citalopram, a selective serotonin reuptake inhibitor (SSRI) antidepressant, can cause QT prolongation and cardiac issues. Caution is advised with high doses or in patients with risk factors for cardiac effects.

Area of Science:

  • Cardiology
  • Pharmacology
  • Psychiatry

Background:

  • Citalopram is a widely prescribed SSRI antidepressant.
  • Recent findings suggest high therapeutic doses may induce electrocardiographic abnormalities.
  • Regulatory bodies have updated citalopram dosage recommendations.

Purpose of the Study:

  • To review existing data on citalopram and cardiac toxicity.
  • To examine cardiac effects associated with both therapeutic use and overdose.

Main Methods:

  • Systematic review of published literature on citalopram's cardiac effects.
  • Analysis of clinical data distinguishing between therapeutic use and overdose scenarios.

Main Results:

  • Electrocardiographic abnormalities, including QT prolongation and torsades de pointes, are known complications of citalopram overdose.

Related Experiment Videos

Last Updated: May 18, 2026

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
12:21

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram

Published on: November 27, 2016

  • QT prolongation and arrhythmia are less common but increasingly recognized with therapeutic doses, with a recently established dose-effect relationship.
  • Patients with metabolic disturbances or pre-existing cardiac conditions are more susceptible to citalopram-induced QT prolongation.
  • Conclusions:

    • A dose-dependent relationship exists for citalopram-induced QT prolongation across various doses.
    • Prescribers should exercise caution with high citalopram doses, especially in patients with co-existing cardiac risk factors.
    • Clinical toxicity data may provide earlier warnings of cardiac effects compared to traditional pharmacovigilance.